Cargando…
CD8(+) T cells specific for conserved coronavirus epitopes correlate with milder disease in patients with COVID-19
A central feature of the SARS-CoV-2 pandemic is that some individuals become severely ill or die, whereas others have only a mild disease course or are asymptomatic. Here, we report the development of an improved multimeric αβ T cell staining reagent platform, with each maxi-ferritin “spheromer” dis...
Autores principales: | Mallajosyula, Vamsee, Ganjavi, Conner, Chakraborty, Saborni, McSween, Alana M., Pavlovitch-Bedzyk, Ana Jimena, Wilhelmy, Julie, Nau, Allison, Manohar, Monali, Nadeau, Kari C., Davis, Mark M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975171/ https://www.ncbi.nlm.nih.gov/pubmed/34210785 http://dx.doi.org/10.1126/sciimmunol.abg5669 |
Ejemplares similares
-
SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?
por: Chakraborty, Saborni, et al.
Publicado: (2021) -
Early peanut introduction wins over the HLA-DQA1*01:02 allele in the interplay between environment and genetics
por: Manohar, Monali, et al.
Publicado: (2022) -
Cosmochemistry
por: McSween, Harry Y, et al.
Publicado: (2010) -
Protective efficacy of influenza group 2 hemagglutinin stem-fragment immunogen vaccines
por: Sutton, Troy C., et al.
Publicado: (2017) -
Learning from HIV-1 to predict the immunogenicity of T cell epitopes in SARS-CoV-2
por: Gao, Ang, et al.
Publicado: (2021)